Craft

Sana Biotechnology

Stock Price

$7

2024-06-07

Market Capitalization

$1.5 B

2024-06-07

Sana Biotechnology Summary

Company Summary

Overview
Sana Biotechnology is a company specializing in cell and gene therapy. It focuses on creating and delivering engineered cells as medicines for patients. The company deploys a platform that can repair and control genes in cells or replace any cell in the body.
Type
Public
Status
Active
Founded
2018
HQ
Seattle, WA, US | view all locations
Website
https://sana.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Steve Harr

    Steve Harr, President and Chief Executive Officer, Director

    • Robin Andrulevich

      Robin Andrulevich, Chief People Officer

    • Nate Hardy

      Nate Hardy, Chief Financial Officer

    • Christian Hordo

      Christian Hordo, Chief Business Officer

    Operating MetricsView all

    Pre-Clinical Phase Products

    14

    Q3, 2020

    LocationsView all

    3 locations detected

    • Seattle, WA HQ

      United States

      188 E Blaine St #400

    • Cambridge, MA

      United States

      300 Tech Square, 300 Technology Square #700

    • South San Francisco, CA

      United States

      1 Tower Pl #500

    Sana Biotechnology Financials

    Summary Financials

    Net income (Q1, 2024)
    ($107.5M)
    Cash (Q1, 2024)
    $177.1M
    EBIT (Q1, 2024)
    ($110.7M)
    Enterprise value
    $1.5B

    Footer menu